港股異動 | 中升控股漲逾4% 耗資740.9萬港元回購 高盛唱多
格隆匯11月29日丨中升控股漲逾4%,報36.6港元,總市值883億港元。公司耗資740.9萬港元回購21.15萬股,每股價格為35.1-34.95港元。此外,高盛發研報,預計跨國汽車製造商將進一步擴大在中國的生產及零售銷售,給予中升控股“買入”評級及確信買入名單,其2024年市盈率僅為5.1倍,低於梅賽德斯2024年5.5倍的遠期市盈率。該行認為,公司的新能源汽車戰略在於頂級廠商的特許經營權,為該股未來增長及差異化的關鍵驅動力。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.